Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
Language: 
English
Short Title: 
Complementary therapies and integrative oncology in lung cancer
Abstract: 

BACKGROUND: This chapter aims to differentiate between "alternative" therapies, often promoted falsely as viable options to mainstream lung cancer treatment, and complementary therapies, adjunctive, effective techniques that treat symptoms associated with cancer and its mainstream treatment, and to describe the evidence base for use of complementary therapies. METHODS AND DESIGN: A multidisciplinary panel of experts in oncology and integrative medicine evaluated the evidence for complementary (not alternative) therapies in the care of patients with lung cancer. Because few complementary modalities are geared to patients with only a single cancer diagnosis, symptom-control research conducted with other groups of patients with cancer was also included. Data on complementary therapies such as acupuncture, massage therapy, mind-body therapies, herbs and other botanicals, and exercise were evaluated. Recommendations were based on the strength of evidence and the risk-to-benefit ratio. RESULTS: Patients with lung and other poor-outlook cancers are particularly vulnerable to heavily promoted claims for unproved or disproved "alternatives." Inquiring about patients' use of these therapies should be routine because these practices may be harmful and can delay or impair treatment. Mind-body modalities and massage therapy can reduce anxiety, mood disturbance, and chronic pain. Acupuncture assists the control of pain and other side effects and helps reduce levels of pain medication required. Trials of acupuncture for chemotherapy-induced neuropathy and postthoracotomy pain show promising results. Herbal products and other dietary supplements should be evaluated for side effects and potential interactions with chemotherapy and other medications. CONCLUSIONS: Complementary therapies have an increasingly important role in the control of symptoms associated with cancer and cancer treatment.

Author(s): 
Cassileth, Barrie R.
Deng, Gary E.
Gomez, Jorge E.
Johnstone, Peter A. S.
Kumar, Nagi
Vickers, Andrew J.
American College of Chest Physicians
Item Type: 
Journal Article
Publication Title: 
Chest
Journal Abbreviation: 
Chest
Publication Date: 
2007-09
Publication Year: 
2007
Pages: 
340S-354S
Volume: 
132
Issue: 
3 Suppl
ISSN: 
0012-3692
DOI: 
10.1378/chest.07-1389
Library Catalog: 
PubMed
Extra: 
PMID: 17873179

Turabian/Chicago Citation

Barrie R. Cassileth, Gary E. Deng, Jorge E. Gomez, Peter A. S. Johnstone, Nagi Kumar, Andrew J. Vickers and American College of Chest Physicians. 2007-09. "Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)." Chest 132: 3 Suppl: 340S-354S. 10.1378/chest.07-1389.

Wikipedia Citation

<ref> {{Cite journal | doi = 10.1378/chest.07-1389 | issn = 0012-3692 | volume = 132 | pages = 340S-354S | last = Cassileth | first = Barrie R. | coauthors = Deng, Gary E., Gomez, Jorge E., Johnstone, Peter A. S., Kumar, Nagi, Vickers, Andrew J., American College of Chest Physicians | title = Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) | journal = Chest | date = 2007-09 | pmid = | pmc = }} </ref>